Identity
- Security key
- 13235
- Ticker
- CDNA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2014-07-17
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- CDNA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $2,447,546,090.13
- Shares outstanding (class)
- 51,734,223
- Shares outstanding (weighted)
- 51,734,223
- SIC
- 8071 SERVICES-MEDICAL LABORATORIES
- Employees
- 765
- Location
- BRISBANE, CA
- Homepage
- https://www.caredx.com
- Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.